Skip to content

Comparison of Nutrition Education Alone or With Acupuncture for Weight Loss in Breast Cancer Patients Post-Chemotherapy

Comparison of Weight Loss Among Early Stage Breast Cancer Patients Post Chemotherapy: Nutrition Education in Combination With Weight Loss Acupuncture Vs. Nutrition Education Alone

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02081612
Enrollment
53
Registered
2014-03-07
Start date
2014-09-30
Completion date
2018-12-01
Last updated
2019-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This study looks at the benefit of adding acupuncture to nutrition education for weight loss in women with early stage breast cancer post-chemotherapy.

Detailed description

Obesity and weight gain are significant concerns for breast cancer survivors. Given the adverse consequences of weight gain after diagnosis, continued efforts to identify appropriate weight management interventions aimed at promoting overall health and long term survivorship are needed. In this study, the investigators will examine whether adding acupuncture to a nutrition education program for weight loss could improve short and long term weight loss among breast cancer survivors post treatment with chemotherapy.

Interventions

BEHAVIORALNutrition Education

12 educational weight management group session each addressing a different weight loss topic

PROCEDUREAcupuncture

12 weight loss acupuncture session using both body and auricular points.

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Woman with a diagnosis of breast cancer, stage I, II, or III * Age ≥ 18 * ECOG performance status ≤ 1 * Received treatment for breast cancer, and treatment must have been completed at least 2 weeks prior to enrollment in trial, but no longer than 1 year post-treatment. * BMI ≥ 30 * Adequate bone marrow and organ function as determined by the consenting/enrolling investigator * Signed informed consent * Any receptor status * Participant is willing and able to comply with the protocol for the duration of the study including undergoing treatment, scheduled visits, and examinations

Exclusion criteria

* Current chemotherapy or radiation therapy. Participants in study may still be receiving hormone or Herceptin treatment. * Diagnosis of metastatic breast cancer * Participation in other diet-based weight loss programs (ie. Patient should not be currently enrolled in Weight Watchers, Jenny Craig, Nutrisystem, etc.) * Current use of commercial or natural/herbal weight loss supplements * Major surgery within 1 month of starting study program and patients must have recovered from any effects of major surgery * Other malignancies within the past three years except for adequately treated carcinoma of the cervix or basal or squamous cell carcinomas of the skin * Personal history of an eating disorder * Other serious, uncontrolled medical disorder, non-malignant systemic disease, or active, uncontrolled infection (including uncontrolled HIV, Hepatitis B or C), or any psychiatric disorder that prohibits obtaining informed consent

Design outcomes

Primary

MeasureTime frame
Weight Loss24 weeks

Secondary

MeasureTime frame
Maintenance of weight loss24 months
Recurrence of breast cancer5 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026